Explore our high-purity API catalog produced under stringent international cGMP and ISO quality standards.
Buy Acetyl Tributyl Citrate Used as Plasticizer and Stabilizer Manufacturers, Factories
View DetailsA comprehensive examination of chemical architecture, targeted Janus Kinase inhibition, and stereo-specific purity control.
Tofacitinib Citrate (Chemical Formula: C16H20N6O · C6H8O7, MW: 504.49 g/mol) is a potent, selective small-molecule oral inhibitor of the Janus Kinase (JAK) family. It specifically targets JAK1 and JAK3 enzymes, effectively blocking the signaling trans-phosphorylation of Signal Transducer and Activator of Transcription (STAT) proteins. This targeted pathway downstream suppresses critical pro-inflammatory cytokines including IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21.
From a synthetic chemistry perspective, achieving absolute chiral resolution at the 3R,4R pyrrolo[2,3-d]pyrimidine backbone is paramount. Gentolex utilizes proprietary asymmetric enzymatic reduction and diastereomeric salt crystallization techniques to guarantee an enantiomeric excess (e.e.) exceeding 99.8%, effectively eliminating unwanted stereoisomers that compromise therapeutic safety profiles.
The bioavailability and dissolution profile of Tofacitinib Citrate oral solid formulations (FDF) depend directly on the control of crystal polymorphism. Our dedicated API crystallization suites produce pure Polymorphic Form I consistently, validated through Powder X-Ray Diffraction (PXRD) and Differential Scanning Calorimetry (DSC).
To cater to diverse drug release systems—including immediate-release, modified-release, and topical dermatological formulations—we offer customized micronization services using fluid energy jet milling. Particle size distributions can be tailored to exact specifications (e.g., D90 < 10 μm, D50 < 3 μm) with controlled specific surface area (SSA) parameters to optimize wet-granulation and direct-compression tableting processes.
Comprehensive analytical benchmarks verified via validated HPLC, GC-MS, LC-MS/MS, and ICP-MS testing protocols.
| Parameter | Analytical Specification | Testing Methodology |
|---|---|---|
| Chemical Name | 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile citrate | IUPAC / InChI Standard |
| CAS Registry Number | 540737-29-9 | CAS Official Index |
| Appearance | White to off-white crystalline powder | Visual inspection |
| Identification (IR, HPLC, PXRD) | Conforms to Reference Standard / Form I Characteristic Peaks | FTIR / PXRD Comparison |
| Assay (HPLC, Anhydrous basis) | 99.0% – 101.0% w/w | USP / Ph. Eur. HPLC Method |
| Enantiomeric Purity (Chiral HPLC) | ≥ 99.8% (3R,4R Isomer); Single Enantiomer ≤ 0.10% | Chiral Stationary Phase HPLC |
| Related Substances (Impurities) | Individual Impurity ≤ 0.10%; Total Impurities ≤ 0.50% | RP-HPLC / LC-MS |
| Heavy Metals / Elemental Impurities | Meets ICH Q3D limits (Pb ≤ 5ppm, As ≤ 1.5ppm, Cd ≤ 0.5ppm, Hg ≤ 1.5ppm) | ICP-MS Method |
| Residual Solvents | Methanol < 3000ppm, Isopropanol < 5000ppm, Ethyl Acetate < 5000ppm | Headspace GC-FID |
| Water Content (Karl Fischer) | ≤ 0.5% w/w | Karl Fischer Coulometric Titration |
| Bacterial Endotoxins | < 0.35 EU/mg (For Parenteral/Specialized Formulations) | LAL Kinetic Chromogenic Method |
Mitigating supply chain risks and empowering global pharmaceutical brands with reliable multi-ton active ingredient sourcing.
Originally approved for moderate to severe Rheumatoid Arthritis (RA), Tofacitinib Citrate has expanded into vast global therapeutic markets including Psoriatic Arthritis, Ulcerative Colitis (UC), Juvenile Idiopathic Arthritis (JIA), and Ankylosing Spondylitis. Furthermore, ongoing clinical investigations into topical alopecia areata and vitiligo solutions are exponentially driving demand for premium micronized raw material APIs.
Global pharmaceutical procurement officers face stringent regulatory hurdles, intermediate shortages, and geopolitical supply volatility. Gentolex resolves these bottlenecks through backwards-integrated key starting material (KSM) synthesis, multi-site backup batch manufacturing, and strategic regional warehousing—ensuring zero supply chain disruption for commercial partners.
To preserve chemical stability and eliminate moisture absorption, Tofacitinib Citrate API is packaged in double food/pharma-grade PE bags placed inside heat-sealed aluminum foil barrier bags, packed within heavy-duty fiber drums (5kg, 10kg, 25kg standard units). Temperature-controlled, cold-chain, and expedite customs clearance arrangements are fully supported worldwide.
Sustainable, scalable, and high-yield chemical synthesis processes engineered for maximum purity and minimal environmental footprint.
Our enhanced commercial synthetic route utilizes 4-chloro-7H-pyrrolo[2,3-d]pyrimidine and (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine as core structural precursors. Key engineering improvements include:
In accordance with ICH M7 guidelines, controlling mutagenic and genotoxic impurities is a core requirement for regulatory approvals. Gentolex's dedicated Analytical R&D team has established quantitative LC-MS/MS assays capable of detecting potential alkylating agents and nitrosamine precursors down to sub-ppm thresholds.
Every single batch of Tofacitinib Citrate API undergoes rigorous testing to guarantee that trace impurities—such as 4-chloropyrrolo[2,3-d]pyrimidine residues and nitrosamine derivatives—remain far below the acceptable toxicological threshold (TTC < 1.5 μg/day).
Connecting global healthcare sectors with certified chemical engineering excellence, robust production capacities, and custom licensing.
Gentolex's goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa.
Our main manufacturing capabilities feature an overall factory construction area of 250,000 square meters under strict international cGMP standards to offer flexible, scalable, and cost-effective solutions. We maintain state-of-the-art cleanrooms (Class 100,000 and Class 10,000), automated synthetic reactors ranging from 100L pilot scale to 5000L commercial scale, and specialized peptide synthesis facilities.
For clients seeking comprehensive commercial partnership, our core competencies include:
Full spectrum CTD/eCTD dossier documentation ensuring rapid regulatory registration across international jurisdictions.
Active Drug Master File (DMF) registered with the US FDA, facilitating seamless reference for ANDA and NDA filings.
Compliant with European Pharmacopoeia (Ph. Eur.) standards, supported by Certificate of Suitability (CEP) documentation.
Inspected and certified by leading national health authorities adhering to ICH Q7 cGMP guidelines for active pharmaceutical ingredients.
Direct local regulatory submission assistance and rapid regional fulfillment through our established hubs in Mexico and South Africa.
Expert answers addressing API procurement, technical specifications, quality assurance, and global logistics.
Stay updated with technological breakthroughs, technical papers, and manufacturing innovations from Gentolex Group.
Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient composed of the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Learn about our large-scale synthesis capabilities...
View Details
As a professional Thymosin Beta-4 API manufacturer and supplier, we provide high-quality Thymosin Beta-4 peptide API solutions for biotechnology companies and research institutions worldwide...
View Details
BPC-157 API is a synthetic pentadecapeptide gaining substantial attention in tissue repair, gastrointestinal protection, and anti-inflammatory pathways. Explore our synthetic analytical control...
View Details
With continuous developments in neuroscience and peptide technology, Semax API stands as an important neuroactive peptide derived from ACTH fragments. Read our technical analysis...
View Details
SS-31 API (Elamipretide) is a targeted mitochondria-stabilizing tetrapeptide designed to support cellular bioenergetics. Learn more about our specialized peptide production lines...
View DetailsDiscover our expanded portfolio of custom synthesized molecules, FDF offerings, and fine chemicals.